43
Growth Score in past quarter
pts
Heat Score 43 in past quarter
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
2394713
Spear Pharmaceuticals is a company that develops specialty dermatological products to fulfill market needs.
- K.L. Spear: President and Dermatologist
About the Company
For more than 25 years, Spear Pharmaceuticals has been committed to making FDA-approved bioequivalent and branded products accessible to the public. The Spear doctrine for bioequivalent drugs is to utilize the same active and inactive ingredients, as well as the same texture, look and consistency, as the branded product. Their commitment to quality
has resulted in FDA approval of eleven first-to-market bioequivalent dermatological products, with several more in the pipeline.